Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Springfield, OH MSA — September 2026
Springfield's mass layoff won't solve life sci's talent problem.
International Motors' 1,341-job closure floods the Springfield labor pool with manufacturing talent just as Ohio reports regulatory affairs hiring difficulty nearly tripling to 31.9% since 2023.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Springfield mass layoff: 1,341 jobs — International Motors plant closure finalizes Oct. 2, 2026
- Regulatory affairs hiring difficulty: 31.9% — Up from 9.3% in 2023 (Ohio survey data)
- Clark County unemployment: 3.8% — vs 3.3% Ohio, 4.1% national (Aug 2026)
- CRA advertised pay, metro: $82,175 — vs $90,956 national median, both rising
Key takeaways
A local manufacturing shock won't fix a national regulatory shortage.
Springfield's 1,341-job plant closure adds production-floor talent to the regional pool, but regulatory affairs and quality roles require credentials this displacement doesn't supply. Compensation strategy for these functions should track national scarcity signals — VP Regulatory Affairs now spans $320K-$580K — rather than assume local softening lowers cost.
Clinical research pay is accelerating faster locally than nationally — in percentage terms.
Metro CRA advertised pay sits at $82,175 against a $90,956 national median, but both are moving up significantly, suggesting employers everywhere are competing harder for clinical talent even in smaller markets. A persistent metro discount may still constrain Springfield-area sites' ability to compete for experienced CRAs against better-funded urban clinical operations.
Displaced manufacturing workers are a training investment, not a hiring shortcut.
Ohio's module-based biomanufacturing training center exists precisely for moments like this, converting dislocated workers into qualified technicians faster than traditional degree pathways. Leaders expanding capacity in or near Springfield may find this the most cost-effective entry point into headcount planning for technician-level production roles.
Lab technician pay softening locally tracks a national pattern, not local weakness alone.
Metro lab tech advertised pay fell to $43,680, a moderate decline mirroring the national $47,402 figure — this looks like a broader compensation correction for entry-level lab roles rather than something specific to Springfield's labor disruption. Worth separating this signal from manufacturing-layoff effects when explaining pay movement to stakeholders.
Median advertised pay by role — Springfield, OH MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $76,330 | $109,195 | $133,227 | Significant increase | $131,354 |
| Clinical Research Associate * | $58,832 | $82,175 | $98,890 | Significant increase | $90,956 |
| Lab Technician * | $38,808 | $43,680 | $47,840 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist * | $69,807 | $97,935 | $116,797 | Significant increase | $104,000 |
| Clinical Data Manager * | $96,493 | $123,869 | $132,982 | Significant decline | $123,031 |
| Biostatistician * | $104,712 | $128,695 | $137,285 | Moderate increase | $133,322 |
| Validation Engineer * | $87,872 | $98,674 | $105,168 | Moderate increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
International Motors' 1,341-position Springfield plant closure, finalizing by October 2, lands against a metro economy already contracting — June employment fell 0.4%, the steepest drop in Ohio, while Clark County unemployment held at 3.8%, above the state's 3.3%. Manufacturing displacement of this scale creates an unusual local dynamic: a surplus of production, quality, and logistics workers entering the candidate pool just as Ohio's life sciences sector reports its sharpest-ever hiring difficulty in regulatory affairs (31.9% "very difficult" in 2025, up from 9.3% in 2023) and quality control (18.9%, up from 5.6%).
What it means
Displaced International Motors workers carry manufacturing discipline — shift operations, quality documentation, materials handling — that maps loosely onto entry-level biomanufacturing roles, but bridging that gap requires structured upskilling rather than assuming direct transferability; Ohio's Life Sciences Training Center model offers a faster, non-degree pathway worth evaluating against this specific labor pool. The scarcity in regulatory affairs and quality roles is a credentialing problem the local layoff does nothing to solve, meaning build-vs-outsource tradeoffs for CMC and regulatory functions remain governed by national competition for experienced talent, not regional labor supply. Organizations should evaluate whether Springfield's manufacturing displacement creates a viable entry-level biomanufacturing pipeline through targeted training partnerships, while continuing to benchmark regulatory and quality compensation against national, not local, scarcity premiums.
Looking ahead
Expected: International Motors' WARN-covered terminations finalize October 2, with Roshel intending new operations at the same sites but no guaranteed workforce transfer. Watch whether Roshel's hiring plans surface any skilled-trades or technical roles adjacent to biomanufacturing needs.
Worth watching: Ohio's labor force has contracted 1.9% statewide even as unemployment falls, a pattern that may understate the true difficulty of filling specialized life sciences roles. If Springfield's displaced workers exit the labor force rather than retrain, the manufacturing layoff provides less talent-pool relief than headline numbers suggest.
Emerging pressure point: Regulatory affairs hiring difficulty nearly tripled in two years statewide (9.3% to 31.9% reporting "very difficult"). Expect continued upward pressure on regulatory and quality compensation benchmarks regardless of local manufacturing conditions.
Potential inflection point: Resilience's Cincinnati biomanufacturing expansion toward 1,100 workers, backed by $825 million in October 2025 financing, signals sustained in-house capacity investment across Ohio's life sciences corridor. Monitor whether this draws experienced CMC and quality talent away from smaller Springfield-area operations.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.